drugset / Trial / NCT07396337
Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of QHRD106 injection in treating acute ischemic stroke.
Timeline
- Start
- 2026-01-19
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QHRD106 | Unknown | 5600 iu | Intravenous |
| Subject | QHRD106 | Unknown | 8400 iu | Intravenous |
| Subject | QHRD106 | Unknown | 12600 iu | Intravenous |